POM121L15P: A Potential Drug Target and Biomarker for Transmembrane Nucleoporin-Like 15

Target Name: POM121L15P

NCBI ID: G102725072

Other Name(s): POM121 transmembrane nucleoporin like 15, pseudogene | POM121L15P variant 1 | POM121 transmembrane nucleoporin like 15, pseudogene, transcript variant 1

POM121L15P: A Potential Drug Target and Biomarker for Transmembrane Nucleoporin-Like 15

POM121L15P, also known as POM121 transmembrane nucleoporin-like 15, is a protein that belongs to the subfamily of nucleoporin-like proteins. It is expressed in various cell types of the human body, including epithelial, muscle, and neural tissues. POM121L15P has been shown to play a critical role in various physiological processes, including cell signaling, cell adhesion, and transcriptional regulation.

Drug Target Potential

POM121L15P has been identified as a potential drug target due to its unique structure and various functions. One of its defining features is its transmembrane nature, which suggests that it may interact with membrane-bound molecules on the intracellular side. Additionally, its amino acid sequence is similar to that of known nucleoporin-like proteins, which may suggest a conserved function.

Several studies have suggested that POM121L15P may be a drug target for various diseases, including cancer, neurodegenerative diseases, and respiratory disorders. For example, some studies have shown that inhibiting POM121L15P activity can lead to therapeutic effects in cancer cells, including a reduction in cell proliferation and the inhibition of angiogenesis.

Biomarker Potential

POM121L15P may also be used as a biomarker for various diseases. Its expression has been shown to be regulated by various factors, including growth factors, chemokines, and pro-inflammatory cytokines. This suggests that its levels may be sensitive to changes in the cellular environment, which could make it an attractive biomarker for diseases associated with inflammation or cellular stress.

Functional assays have also shown that POM121L15P can be used as a protein biomarker for various diseases, including cancer. For example, some studies have shown that POM121L15P levels are regulated by factors such as cancer-associated fibrosis, which suggests that it may be a potential biomarker for cancer.

Conclusion

POM121L15P is a protein that has been identified as a potential drug target due to its unique structure and various functions. Its transmembrane nature and conservation in amino acid sequence suggest that it may interact with membrane-bound molecules on the intracellular side. Additionally, its expression has been shown to be regulated by various factors, including growth factors, chemokines, and pro-inflammatory cytokines, which suggests that its levels may be sensitive to changes in the cellular environment.

Furthermore, several studies have shown that POM121L15P can be used as a protein biomarker for various diseases, including cancer. Its expression has been shown to be regulated by factors such as cancer-associated fibrosis, which suggests that it may be a potential biomarker for cancer.

Overall, POM121L15P is a promising protein that may be a drug target or biomarker for various diseases. Further research is needed to fully understand its functions and potential applications in medicine.

Protein Name: POM121 Transmembrane Nucleoporin Like 15, Pseudogene

More Common Targets